BGMS · Bio Green Med Solution, Inc.
$0.84
-0.01 (-1.19%)
At close · Sep 2
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Our history of losses, our negative cash flows from operations, our liquidity resources currently on hand, and our dependence on the ability to obtain additional financing to fund our operations after the current resources are exhausted, about which there can be no certainty, have resulted in our assessment that there is substantial doubt about our ability to continue as a going concern for a period of at least twelve months from the issuance date of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 14, 2026
Market Cap
$5.73M
Shares
6.62M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $585,000 |
| Paul McBarron | Executive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary | $333,623 |
| Mark Kirschbaum | MD, Former Senior Vice President and Chief Medical Officer^ | $30,365 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $661,049 |
| Mark Kirschbaum | MD, Former Senior Vice President and Chief Medical Officer^ | $480,618 |
| Paul McBarron | Executive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary | $352,615 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $763,551 |
| Mark Kirschbaum | Former Senior Vice President and Chief Medical Officer | $523,843 |
| Paul McBarron | Executive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary | $394,675 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $1,339,226 |
| Mark Kirschbaum | Senior Vice President and Chief Medical Officer | $794,576 |
| Paul McBarron | Executive Vice President, Finance, Chief Financial Officer, Chief Operating Officer, Secretary | $707,860 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer 2020 | $1,409,644 |
| Paul McBarron | Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary | $828,712 |
| Mark Kirschbaum | Senior Vice President and Chief Medical Officer | $454,135 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $1,014,471 |
| Judy Chiao | Vice President, Clinical Development and Regulatory Affairs | $671,121 |
| Paul McBarron | Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary | $542,290 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Spiro Rombotis | President and Chief Executive Officer | $752,824 |
| Judy Chiao | Vice President, Clinical Development and Regulatory Affairs | $529,733 |
| Paul McBarron | Executive Vice President, Finance, Chief Operating Officer, Chief Financial Officer, Secretary | $387,994 |